Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

April 19, 2026

Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

April 18, 2026

Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results

April 18, 2026

Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights!

April 18, 2026

Raptors fall to Cavaliers in Game 1 as Toronto returns to playoffs

April 18, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » NUSCALE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NuScale To Contact Him Directly To Discuss Their Options
Press Release

NUSCALE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NuScale To Contact Him Directly To Discuss Their Options

By News RoomNovember 26, 20233 Mins Read
NUSCALE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NuScale To Contact Him Directly To Discuss Their Options
Share
Facebook Twitter LinkedIn Pinterest Email

If you purchased or acquired securities in NuScale between March 15, 2023 and November 8, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SMR.

There is no cost or obligation to you.

NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) and reminds investors of the January 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) due to the impact of inflationary pressures on the cost of construction and power, the Company and UAMPS would be unable to sign up enough subscribers to fulfill the CFPP; (2) Standard Power did not have the financial ability to support its agreement with NuScale; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On the morning of October 19, 2023, Iceberg Research issued a research report that contradicted NuScale’s claims that it would be able to fulfill two large contracts: (1) a contract with the Utah Associated Municipal Power Systems (“UAMPS”) for its Carbon Free Power Project (“CFPP”), and (2) a contract with Standard Power, a company providing data center services for businesses focusing on blockchain mining and high performance computing applications.

On October 19, 2023, the Company’s share price fell $0.58 per share, or 11.50%, to close at $4.46 per share, on unusually high trading volume.

Then on November 8, 2023, NuScale and UAMPS announced that they had mutually agreed to terminate the CFPP contract because they had failed to engage enough subscribers.

On this news, the Company’s share price fell $1.02 per share, or 32.90%, to close at $2.08 per share on November 9, 2023, on unusually high trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.  

Faruqi & Faruqi, LLP also encourages anyone with information regarding NuScale’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results

Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights!

1922 Revisited Returns to a Pivotal Moment in Venice Biennale History

Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status

BitsStrategy Unveils a Quantum AI Trading App Designed for Faster, Data-Driven Trading Decisions

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

As DC Prepares for Its First-Ever Ranked Choice Voting Primary in June, New Documentary Captures the Nationwide Movement to Make Elections Work for Voters, Not Parties

Editors Picks

Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

April 18, 2026

Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results

April 18, 2026

Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights!

April 18, 2026

Raptors fall to Cavaliers in Game 1 as Toronto returns to playoffs

April 18, 2026

Latest News

1922 Revisited Returns to a Pivotal Moment in Venice Biennale History

April 18, 2026

Nova Scotia’s provincewide ban on entering the woods was unreasonable, court rules

April 18, 2026

Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status

April 18, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version